Clinical Trials
3 trialsNCT00590954 2020-10-19
Clinical and Molecular-Metabolic Phase II Trial of Perifosine for Recurrent/Progressive Malignant Gliomas
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT00058214 2015-02-23
Perifosine in Treating Patients With Recurrent Prostate Cancer
National Cancer Institute (NCI)
Phase 2 Terminated
NCT00064324 2013-06-04
Perifosine in Treating Patients With Advanced Soft Tissue Sarcoma
National Cancer Institute (NCI)
Phase 2 Completed